Myositis is a disorder in which the immune system attacks the muscles. It is hoped that this new treatment may help improve the symptoms of this disease.

Research Objectives

Status

Current

Recruitment

Open

Patient Group

Idiopathic Inflammatory Myopathy/Myositis Status: Current

Study location

Wesley Research Institute

Phase

3

Study type

Industry Sponsored

Sponsors: Argenx BV (global) and ICON Clinical Research Pty Ltd (Local)

    Lead investigator    
            Dr Daman Langguth        

        Clinical trial coordinator		
				Venita Bali			

Technical title

A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathies

About this research project

The research project is testing a new treatment for Active Idiopathic Inflammatory Myopathy. This is a disorder in which the immune system attacks the muscles. This leads to muscle weakness and may affect other organs of the body.

The potential new treatment being tested is called efgartigimod (also called ARGX113). It is hoped that efgartigimod may help improve the symptoms of myositis.

Latest News

AI Initiative Targets ‘Beeps and Bongs’ to Revolutionise ICU Care

A research initiative aiming to leverage Artificial Intelligence’s capabilities to detect early signs of patient deterioration, especially in those undergoing mechanical ventilation, is receiving significant backing from the Wesley Research Institute. At the helm of this innovative project are Dr James Winearls and Professor John Fraser.

Pioneering Research to Advance Pandemic Protection for Youth

A novel research initiative spearheaded by Professor John Fraser and Associate Professor Kirsty Short, is set to lay the groundwork for vaccines and treatments aimed at protecting children and young adults during health crises.

Empowering Cancer Survivors Through Innovative Exercise Therapy

Dr Janine Porter-Steele and Professor Alexandra (Sandie) McCarthy are leading the FOXTROT project, focusing on delivering telehealth exercise therapy to cancer survivors living with ostomies.

1 2 3 … 11 Next »

Rare Diseases

Testing treatments to improve symptoms of Myositis